JMP Securities Lifts Price Target On Oncothyreon (ONTY) to $14
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Oil rally pressures S&P, Nasdaq; Microsoft, Salesforce buoy Dow
- Oil prices rise 2% as attacks on Saudi Arabia overshadow Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts ONTY Hot Sheet
Price: $1.21 --0%
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Rating Summary:
7 Buy, 2 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 20 | New: 46
Join SI Premium – FREE
Earlier, JMP Securities boosted its price target on Market Outperform-rated Oncothyreon (NASDAQ: ONTY) from $8 to $14.
For an analyst ratings summary and ratings history on Oncothyreon click here. For more ratings news on Oncothyreon click here.
Shares of Oncothyreon are up 1 percent in early trade to $6.29 with a 52 week range of $2.99-$11.59.
For an analyst ratings summary and ratings history on Oncothyreon click here. For more ratings news on Oncothyreon click here.
Shares of Oncothyreon are up 1 percent in early trade to $6.29 with a 52 week range of $2.99-$11.59.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) PT Raised to $220 at BMO Capital
- Jefferies: 'we estimate that Starlink is on 9% of aircraft today and will be on 23% by 2028'
- Baird on Mirum Pharmaceuticals (MIRM): 'we expect upside for the stock'
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
